PAPER Ende N, Chen R, Ende-Harris D
SEARCH RESULTS
344037 RESULTS
PAPER Casanova MF, Hill WD, Pourdihimi B
Senile plaques exert no mass lesion effect on surrounding neurons.
J Neurosci Methods. 2001 Sep 30;110(1-2):125-33. PubMed.PAPER Nacmias B, Tedde A, Forleo P, Piacentini S, Guarnieri BM, Bartoli A, Ortenzi L, Petruzzi C, Serio A, Marcon G, Sorbi S
Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease.
Biol Psychiatry. 2001 Sep 15;50(6):472-5. PubMed.PAPER Janus C, Westaway D
Transgenic mouse models of Alzheimer's disease.
Physiol Behav. 2001 Aug;73(5):873-86. PubMed.PAPER Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davis RJ, Shirasaki Y, Greenberg ME
Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.
J Neurosci. 2001 Oct 1;21(19):7551-60. PubMed.PAPER Yu H, Saura CA, Choi SY, Sun LD, Yang X, Handler M, Kawarabayashi T, Younkin L, Fedeles B, Wilson MA, Younkin S, Kandel ER, Kirkwood A, Shen J
APP processing and synaptic plasticity in presenilin-1 conditional knockout mice.
Neuron. 2001 Sep 13;31(5):713-26. PubMed.PAPER Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelsø C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nägga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.
Clin Chem. 2001 Oct;47(10):1776-81. PubMed.PAPER Downes JJ, Priestley NM, Doran M, Ferran J, Ghadiali E, Cooper P
Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease.
Behav Neurol. 1998;11(3):173-183. PubMed.PAPER Bédard MA, Lemay S, Gagnon JF, Masson H, Paquet F
Induction of a transient dysexecutive syndrome in Parkinson's disease using a~subclinical dose of scopolamine.
Behav Neurol. 1998;11(4):187-195. PubMed.PAPER Rösler M, Retz W, Retz-Junginger P, Dennler HJ
Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer's disease.
Behav Neurol. 1998;11(4):211-216. PubMed.PAPER Vecchi T, Saveriano V, Paciaroni L
Storage and processing working memory functions in Alzheimer-type dementia.
Behav Neurol. 1998;11(4):227-231. PubMed.PAPER Arango D, Cruts M, Torres O, Backhovens H, Serrano ML, Villareal E, Montañes P, Matallana D, Cano C, Van Broeckhoven C, Jacquier M
Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.
Am J Med Genet. 2001 Oct 1;103(2):138-43. PubMed.PAPER Chen P, Ratcliff G, Belle SH, Cauley JA, Dekosky ST, Ganguli M
Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study.
Arch Gen Psychiatry. 2001 Sep;58(9):853-8. PubMed.PAPER Small BJ, Fratiglioni L, Bäckman L
Canaries in a coal mine: cognitive markers of preclinical Alzheimer disease.
Arch Gen Psychiatry. 2001 Sep;58(9):859-60. PubMed.PAPER Benussi L, Alberici A, Mayhaus M, Langer U, Ghidoni R, Mazzoli F, Nicosia F, Barbiero L, Frisoni G, Zanetti O, Gasparini L, Nitsch RM, Binetti G
Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: a release enhanced by apoptosis.
Exp Cell Res. 2001 Oct 1;269(2):256-65. PubMed.Current Filters
No filters selected